CytomX Therapeutics, Inc. (FRA:6C1)
3.374
+0.086 (2.62%)
At close: Dec 4, 2025
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of €592.79 million as of December 5, 2025. Its market cap has increased by 827.51% in one year.
Market Cap
592.79M
Enterprise Value
474.43M
Revenue
96.85M
Ranking
n/a
PE Ratio
24.82
Stock Price
€3.37
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from 399.33M to 592.79M, an increase of 48.45%. That is a compound annual growth rate of 3.96%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |